415
Participants
Start Date
February 1, 2019
Primary Completion Date
June 28, 2019
Study Completion Date
July 12, 2019
Tolperisone
TID
Placebo
Placebo
Upstate Clinical Research Associates, Williamsville
Frontier Clinical Research, Inc., Smithfield
Center for Rheumatology and Bone, Wheaton
Health Research of Hampton Roads, Inc., Newport News
Clinical Trials of America, Winston-Salem
Georgia Institute for Clinical Research, Marietta
Georgia Clinical Research, Snellville
NeuroTrials Research, Inc., Atlanta
Riverside Clinical Research, Edgewater
Empirical Research Group, Gainesville
Avail Clinical Research, Orange City
Savin Medical Group, Miami Lakes
LLC Medical Research, Miami
Private Practice, Plantation
Tennessee Valley Pain Consultants, Huntsville
Otrimed Clinical Research, Edgewood
Cleveland Clinic, Cleveland
Sterling Research Group- Springdale, Cincinnati
Center for Providence Health Partners, Dayton
MediSphere Medical Research Center, Evansville
Michigan Head Pain and Neurological, Ann Arbor
Health Concepts, Rapid City
Sundance Clinical Research, St Louis
Centex Studies, Inc., Lake Charles
Center of Applied Research, Little Rock
IPS Research, Oklahoma City
ClinRX Research Joseph, Inc., Plano
HD Research Corp, Houston
Inquest Clinical Research, Baytown
DiscoveResearch, Inc., Bryan
Centex Studies, Inc., McAllen
Highland Clinical Research, Salt Lake City
Fiel Family and Sports Medicine, Tempe
Albuquerque Clinical Trials, Inc., Albuquerque
Jubilee Clinical Research, Las Vegas
Long Beach Clinical Trials Services, Inc., Long Beach
Pacific Research Network, LLC, San Diego
San Diego Sports Medicine, San Diego
CITrials, Santa Ana
Research Center of Fresno, Fresno
Northern California Research, Sacramento
Williamette Valley Clinical Studies, Eugene
Omega Medical Research, Warwick
Lead Sponsor
Neurana Pharmaceuticals, Inc.
INDUSTRY